Protein Palace

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEF ADVANCED RESEARCH PROJECTS AGCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

DARPA-PA-27-02

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

AC12

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
The Defense Advanced Research Projects Agency (DARPA), operating under the Department of Defense, has issued a solicitation titled "Protein Palace" (Procurement Identifier: DARPA-PA-27-02). This opportunity seeks innovative proposals focused on the tunable purification of any protein from complex feedstocks. The primary objective is to advance the science, devices, or systems associated with protein purification, specifically targeting revolutionary—not incremental—improvements beyond the current state of practice. DARPA is looking for research and development efforts that can deliver groundbreaking solutions in the physical, engineering, and life sciences, as classified under NAICS Code 541715. Notably, this classification excludes nanotechnology and biotechnology, emphasizing a broader scientific and engineering scope. The Product Service Code AC12 further identifies this as a research and development initiative in the life sciences. The scope of the solicitation encompasses the development of novel methodologies, technologies, or systems capable of isolating proteins from complex mixtures with tunable specificity and efficiency. The intended outcome is to enable transformative capabilities in protein purification, which could have far-reaching implications for scientific research, medical applications, and industrial processes. DARPA explicitly excludes proposals that offer only evolutionary improvements, underscoring its commitment to disruptive innovation. The contracting entity is the Defense Advanced Research Projects Agency, a federal office within the Department of Defense. The solicitation is managed by the PA Coordinator, who can be reached at [email protected] for further inquiries. The notice is currently active, with a posting date of December 11, 2026, and a response deadline of January 22, 2027. Interested parties can access the solicitation and its attachments via the official SAM.gov opportunity page (https://sam.gov/opp/5d847e7708d64d70baea8f54b259cb7c/view), where thirteen supporting documents are available for review. This procurement is classified as a solicitation, indicating that DARPA is seeking competitive proposals from qualified entities. There is no mention of set-aside requirements or special considerations in the provided information, suggesting that the opportunity is open to all eligible organizations capable of meeting the technical and scientific demands of the project. Contractors evaluating this opportunity should ensure their capabilities align with DARPA’s emphasis on revolutionary advances in protein purification. Proposals should demonstrate innovative approaches, robust scientific merit, and the potential for significant impact. The core elements of the solicitation—including its focus on disruptive innovation, the broad scientific scope, and the federal contracting context—will remain constant throughout the contract lifecycle.
Documents13